ADVFN UK Market News

Category: Top Story

  • Fuller’s Increases Earnings, Dividend and Estate Investment Following Strong Trading Performance (FSTA)

    Fuller’s Increases Earnings, Dividend and Estate Investment Following Strong Trading Performance (FSTA)

    Fuller, Smith & Turner (LSE:FSTA) delivered another year of growth, reporting revenue of £397.8 million for the period, up 5.7% from the previous year. Like-for-like sales across its Managed Pubs and Hotels division increased 4.9%, helping drive adjusted profit before tax 28% higher to £34.6 million.

    The strong financial performance translated into a 38% increase in adjusted earnings per share, allowing the company to raise its total dividend by 7% to 21.20p. Management highlighted the resilience of the group’s predominantly freehold estate as a key contributor to its continued progress.

    During the year, Fuller’s invested £32.2 million across its portfolio, including the acquisition of two freehold pubs in central London and continued spending on staff development and training programmes. The company also maintained a disciplined approach to capital allocation through share buybacks and balance sheet management, supported by a property estate valued at approximately £991 million.

    Trading momentum has continued into the current financial year, with like-for-like sales rising 4.4% during the first 10 weeks. Looking ahead, Fuller’s plans to invest more than £30 million in its estate, including the addition of new hotel rooms at its London Bridge location. Management believes these investments will support future growth opportunities as the business enters the busy summer period and benefits from major sporting events.

    The company’s outlook is supported by solid trading performance, ongoing investment and positive operational momentum. While further improvements in metrics such as free cash flow generation and return on equity could strengthen the investment case, Fuller’s believes its premium estate, strong balance sheet and carefully targeted capital expenditure leave it well positioned for continued progress.

    More about Fuller Smith & Turner

    Fuller, Smith & Turner is a premium pubs and hotels operator with a portfolio comprising 185 managed pubs and hotels and 152 tenanted inns, primarily located across southern England. The group offers fresh seasonal food, a broad drinks selection and 1,030 hotel rooms, catering to customers seeking high-quality pub, dining and accommodation experiences. The business is supported by a workforce of more than 5,000 employees.

  • Wall Street Futures Rise as Lower Oil Prices Boost Market Sentiment: Dow Jones, S&P, Nasdaq

    Wall Street Futures Rise as Lower Oil Prices Boost Market Sentiment: Dow Jones, S&P, Nasdaq

    U.S. equity futures traded higher on Tuesday, indicating a stronger start for Wall Street as investors reacted positively to a sharp decline in oil prices and continued to assess prospects for easing tensions in the Middle East.

    The drop in energy prices provided early support for risk assets, with U.S. crude futures falling more than 2%.

    Oil slipped below the $90-per-barrel mark after President Donald Trump suggested that a peace agreement between the United States and Iran could be reached within “two or three days.”

    Trump also said the Strait of Hormuz would reopen “immediately” once an agreement is finalized, although previous predictions of a near-term breakthrough have yet to produce a formal deal.

    The market may also continue to benefit from bargain-hunting activity after Friday’s broad-based sell-off left many stocks trading at reduced levels.

    Stocks rebounded sharply at the start of Monday’s session following the previous week’s losses, but much of that momentum faded throughout the day. By the closing bell, the major indices had retreated significantly from their highs, with the Dow ending modestly lower.

    The Nasdaq, which had gained as much as 1.8% intraday, finished up 220.23 points, or 0.9%, at 25,929.66. The S&P 500 rose 21.99 points, or 0.3%, to 7,405.73, while the Dow Jones Industrial Average slipped 80.77 points, or 0.2%, to 50,786.01.

    Much of Monday’s early strength stemmed from investors stepping back into technology shares after Friday’s sell-off pushed the Nasdaq to its weakest close in a month.

    However, buying activity slowed as traders monitored ongoing geopolitical risks, including reports that Israel and Iran exchanged missile strikes over the weekend.

    Crude prices later eased after Trump stated that Israel and Iran were “looking to do an immediate ceasefire.”

    “Final negotiations on ‘Peace’ are proceeding, subject to ignorance or stupidity getting in its way,” Trump said in a post on Truth Social. “The Blockade will remain in place, and in full force and effect, until a ‘Final Deal’ is reached. Things should move quickly.”

    Semiconductor stocks remained a notable area of strength throughout the session. The Philadelphia Semiconductor Index climbed 5.6%, recovering part of the steep 10.3% decline recorded on Friday.

    Marvell Technology (NASDAQ:MRVL) surged 9.6% after confirmation that the company will be added to the S&P 500, alongside electronics manufacturing services provider Flex (NASDAQ:FLEX).

    Nvidia (NASDAQ:NVDA) gained 1.7% after announcing a long-term partnership with SK hynix focused on developing advanced memory technologies for AI infrastructure and speeding up semiconductor innovation.

    Energy-related shares also performed well, with the Philadelphia Oil Service Index advancing 3.6%.

    Oil producers and computer hardware companies ended the session among the strongest performers, while utilities and commercial real estate stocks lagged as Treasury yields continued to move higher.

  • European Markets Advance as Hopes Grow for Israel-Iran De-Escalation: DAX, CAC, FTSE100

    European Markets Advance as Hopes Grow for Israel-Iran De-Escalation: DAX, CAC, FTSE100

    European equities traded mostly higher on Tuesday as easing tensions between Israel and Iran supported investor sentiment. The U.S. dollar retreated from a two-month high, while Brent crude slipped below $93 per barrel after both countries agreed to suspend attacks, raising expectations that diplomatic efforts could gain momentum.

    Market confidence also received a boost from fresh economic data showing strong growth in both Chinese exports and imports during May.

    In Europe, official figures showed German industrial production rose 0.4% month-on-month in April, reversing a revised 0.1% decline recorded in March, according to Destatis.

    The result matched market expectations and marked the first monthly increase in industrial output in five months.

    Separate data indicated that German exports increased 0.9% in April compared with the previous month, accelerating from March’s 0.3% gain. Economists had anticipated a 0.3% decline.

    The French CAC 40 advanced 0.7%, while Germany’s DAX gained 0.5%. In contrast, the UK’s FTSE 100 slipped 0.3%, weighed down by weakness in energy stocks including BP Plc and Shell.

    Among corporate movers, shares of Technip (EU:TE), Airbus (EU:AIR) and Safran (EU:SAF) moved higher after the French companies partnered with Tereos on a sustainable aviation fuel production initiative in France.

    In London, scientific instruments specialist Oxford Instruments (LSE:OXIG) dropped 6.5% despite delivering full-year results that modestly exceeded expectations.

    Housebuilder Bellway (LSE:BWY) climbed 3% after reaffirming its profit outlook for fiscal 2026.

    Keller Group (LSE:KLR) gained 3% after announcing a $207 million contract variation related to a major highway reconstruction project in the United States.

    Meanwhile, GSK (LSE:GSK) fell 3.5% after agreeing to acquire U.S.-listed oncology company Nuvalent in a deal valued at $10.6 billion.

  • Molten Ventures Delivers Strong FY26 Performance as Portfolio Winners Continue to Scale

    Molten Ventures Delivers Strong FY26 Performance as Portfolio Winners Continue to Scale

    Molten Ventures (LSE:GROW) has reported an impressive set of results for the year ended 31 March 2026, underlining the strength of its portfolio, disciplined capital allocation strategy and ability to identify category-leading technology businesses long before they reach the mainstream investment radar.

    The venture capital investor delivered a strong year of growth, with Net Asset Value (NAV) per share increasing by 13% to approximately 760p and Gross Portfolio Value rising to more than £1.5 billion. The performance was driven by a combination of operational progress across the portfolio, successful funding rounds and the continued impact of the company’s share buyback programme.

    Importantly, the growth was not driven by accounting adjustments alone. Molten generated £120 million of cash proceeds from realisations during the year at an average multiple of around three times invested capital, demonstrating the ability to convert portfolio value into cash while continuing to recycle capital into the next generation of growth opportunities. The company invested £89 million during FY26 and returned £38 million to shareholders through buybacks, helping to enhance NAV per share and narrow the discount at which the shares trade relative to underlying asset value.

    A key driver of the year’s performance was the continued success of several core portfolio holdings, including space technology leader ICEYE, fintech giant Revolut, digital asset security specialist Ledger and quantum computing business Riverlane. These businesses were among the largest contributors to portfolio value growth during the year.

    Since the financial year-end, investors have received further evidence of the quality embedded within the portfolio. ICEYE today announced a landmark Series F financing round that raised more than €450 million in primary funding, valuing the company at over €10 billion; including a secondary placement, the total transaction exceeded €1 billion. The funding round was led by major global investors and highlights the growing strategic importance of ICEYE’s satellite intelligence capabilities to governments and commercial customers worldwide.

    For Molten Ventures shareholders, the significance extends beyond the headline valuation. Because the round completed after the 31 March year-end, it is not reflected in today’s audited NAV. At the new valuation, Molten’s ICEYE holding rises to £317 million – a £238 million gain – lifting NAV per share from 760p to approximately 877p. As part of the round, Molten also realised a further circa £22 million in secondary proceeds

    ICEYE has already been one of the strongest contributors to Molten’s NAV growth and realisation programme, with previous partial exits generating exceptional returns. The latest financing round provides further third-party validation of the company’s long-term value creation potential and demonstrates Molten’s ability to identify transformational businesses at an early stage and support them through multiple phases of growth.

    The success of ICEYE also illustrates a broader theme across the Molten portfolio. Many of its core holdings are operating in sectors benefiting from powerful structural growth drivers, including fintech, artificial intelligence, quantum computing, cybersecurity and space technology. As these businesses mature, the opportunity for further valuation uplifts, strategic exits and public market listings remains significant.

    Looking ahead, Molten enters FY27 from a position of strength. The company maintains substantial liquidity, a highly diversified portfolio and a growing secondaries investment capability designed to capitalise on opportunities across the European venture ecosystem. Core portfolio revenue growth remained strong during FY26, highlighting the operational progress being achieved by portfolio companies despite a challenging funding environment.

    Investors will have the opportunity to hear directly from management when Molten Ventures presents its FY26 results via the Investor Meet Company platform on 12 June 2026 at 10:30am BST. The presentation will provide additional insight into the year’s performance, portfolio developments, capital allocation priorities and outlook for the year ahead, together with a live Q&A session for shareholders.

    With NAV growing at a double-digit rate, successful realisations continuing, shareholder returns being enhanced through buybacks and portfolio companies such as ICEYE achieving landmark funding milestones, Molten Ventures appears increasingly well positioned to unlock further value from one of Europe’s most compelling technology investment portfolios. The FY26 results reinforce the view that the company is successfully navigating the venture capital cycle while creating long-term value for shareholders.

    For more information visit – https://www.moltenventures.com/

  • European Stocks Trade Mixed as Investors Monitor Middle East Developments and ECB Outlook: DAX, CAC, FTSE100

    European Stocks Trade Mixed as Investors Monitor Middle East Developments and ECB Outlook: DAX, CAC, FTSE100

    European equity markets showed little clear direction on Tuesday as investors weighed signs of easing tensions in the Middle East while looking ahead to the European Central Bank’s upcoming interest rate decision.

    By 03:04 ET (07:04 GMT), the pan-European Stoxx 600 was broadly flat. Germany’s DAX slipped 0.1%, France’s CAC 40 traded near unchanged levels, and the UK’s FTSE 100 fell 0.4%.

    Sentiment was supported by announcements from Iran and Israel that they had suspended their recent exchange of attacks, helping to calm concerns over regional instability and raising hopes that U.S. President Donald Trump may be able to secure a diplomatic agreement with Tehran.

    However, uncertainty remained elevated. The Strait of Hormuz, a critical route for around one-fifth of global oil and liquefied natural gas shipments, continues to face severe restrictions on tanker traffic, while Trump has indicated that the U.S. blockade of Iranian ports will remain in force.

    Brent crude, the international oil benchmark, declined 1.0%, although prices remain significantly above levels seen before the conflict. At the same time, Eurozone government bond yields moved lower as investors sought safer assets.

    Markets remain alert to the risk that higher energy costs could fuel another wave of inflation, potentially prompting central banks to maintain a restrictive policy stance.

    The European Central Bank is widely expected to raise interest rates on Thursday as policymakers continue to focus on controlling inflation despite signs of slowing economic momentum across the 21-country euro area. In the United States, investors are also increasingly pricing in another rate increase from the Federal Reserve before year-end, following stronger-than-expected employment data released in May.

    On the corporate front, GlaxoSmithKline (LSE:GSK) shares fell 2.1% after the pharmaceutical group announced an agreement to acquire oncology company Nuvalent for $10.6 billion. The transaction will provide GSK with access to three lung cancer treatment candidates and further strengthen its oncology pipeline.

  • FTSE 100 Edges Lower as Iran-Israel Negotiations Near Endgame

    FTSE 100 Edges Lower as Iran-Israel Negotiations Near Endgame

    UK equities traded lower on Tuesday morning as investors assessed a fragile pause in hostilities between Iran and Israel. Market sentiment remained cautious after U.S. President Donald Trump suggested negotiations were in their “final throes”, while both countries signalled that military action could resume if talks fail. Additional uncertainty emerged after reports of a U.S. military helicopter crash near the Strait of Hormuz.

    The FTSE 100 fell 0.41% by 03:23 ET (07:23 GMT). Across Europe, Germany’s DAX declined 0.14%, while France’s CAC 40 managed a gain of 0.30%. Sterling strengthened modestly against the U.S. dollar, rising 0.19% to 1.3367.

    Speaking to reporters at New York’s JFK Airport on Monday, Trump said Iran and Israel “were going back and forth and now they both agreed, through me, to stop,” adding that a final agreement could be reached within “two or three days.”

    Meanwhile, the New York Times reported that a U.S. Army Apache helicopter crashed near the Strait of Hormuz on Monday. The cause of the incident remains unknown, although Trump confirmed that both pilots were unharmed.

    Separately, U.S. Central Command said it had disabled an empty oil tanker in the Gulf of Oman after the vessel allegedly breached a U.S. naval blockade by attempting to reach an Iranian port.

    Iran’s military leadership announced a suspension of operations on Monday after launching around 30 ballistic missiles at Israel since Sunday evening, describing the attacks as a “painful response” in support of Lebanon. Israel agreed to halt military action following a request from Washington, although Prime Minister Benjamin Netanyahu warned that if Iran were to “make the mistake of resuming attacks against us, we will respond with full force.”

    The Israeli military issued new evacuation notices for residents of Tyre in southern Lebanon on Tuesday. Highlighting the political complexities surrounding the conflict, a senior U.S. official told Axios, “Bibi needs the war to continue to stay politically alive in Israel, and Trump needs the war to end to stay politically alive in the U.S.”

    Iran’s ambassador to the United Nations, Amir Saeid Iravani, told the Associated Press that he hoped a final agreement would be reached “soon.” However, an Iranian official told Al Jazeera that recent U.S. amendments to a draft memorandum remained unacceptable, stating that “without the release of frozen assets and the lifting of sanctions, no deal is possible.”

    According to the Wall Street Journal, the United States has dropped efforts to immediately refer Iran to the UN Security Council as part of a compromise aimed at securing European support for a joint resolution at the International Atomic Energy Agency’s Board of Governors.

    UK Corporate Round-Up

    MJ Gleeson (LSE:GLE) warned that annual adjusted pre-tax profit is likely to fall below current market expectations after delays to a major land sale, which represents roughly half of its anticipated plot sales for the current financial year.

    Fellow housebuilder Bellway (LSE:BWY) reported softer customer demand after a strong start to the spring selling season, while rising fuel and energy costs continue to place pressure on profitability.

    GSK (LSE:GSK) announced an agreement to acquire U.S.-listed oncology specialist Nuvalent in a $10.6 billion all-cash transaction. The offer values Nuvalent at $124 per share, representing a 40% premium to the company’s previous closing price, and is intended to strengthen GSK’s position in lung cancer treatments.

    Meanwhile, investors in BP (LSE:BP.) remain unclear about the circumstances surrounding the departure of former chairman Albert Manifold in May, according to a report by the Financial Times.

  • Market Open: Bellway Demand Outlook, GSK Nuvalent Acquisition

    Market Open: Bellway Demand Outlook, GSK Nuvalent Acquisition

    FTSE 100 slips as investors monitor easing Middle East tensions. Bellway maintains guidance while GSK agrees an £8bn cancer drug acquisition.

    Market Overview

    European markets were mixed at the open as easing tensions in the Middle East helped stabilise investor sentiment. The FTSE 100 slipped 0.27 per cent to 10,325.57, while the CAC 40 fell 0.23 per cent and the DAX lost 0.58 per cent. In contrast, US markets finished higher overnight, with the Nasdaq gaining 0.65 per cent and the S&P 500 adding 0.31 per cent. Investors continued to assess developments around Iran-Israel ceasefire efforts and the potential implications for energy markets and broader risk appetite.

    Commodity markets reflected improving geopolitical sentiment. Brent crude moved lower after recent volatility linked to Middle East tensions, while copper and natural gas advanced. Gold was little changed as safe-haven demand eased. Sterling strengthened against the US dollar, euro, Japanese yen, Swiss franc and Australian dollar, while Bitcoin weakened against the pound. Markets remain focused on geopolitical developments, energy prices and the outlook for global economic growth.

    Market Numbers

    FTSE 100: Down (-0.27%), 10,325.57

    CAC40: Down (-0.23%), 8,199.290

    DAX: Down (-0.58%), 24,616.22

    NASDAQ: Up (0.65%), 29,573.0

    S&P 500: Up (0.31%), 7,425.0

    In the Headlines

    Spring Demand Slows – Bellway (LSE:BWY)

    Bellway said higher mortgage costs softened demand during the spring selling season, although reservation rates and cancellation levels remained broadly stable. The housebuilder maintained its full-year profit and completion guidance, signalling confidence in underlying market conditions despite affordability pressures.

    Cancer Drug Acquisition – GSK (LSE:GSK)

    GSK has agreed to acquire US lung cancer specialist Nuvalent in a deal worth approximately £8 billion. The transaction strengthens GSK’s oncology pipeline and underlines the company’s strategy of expanding its portfolio of targeted cancer treatments.

    Currencies (vs GBP)

    USD: Up (0.20%), $1.3365

    CHF: Up (0.09%), Fr.1.06506

    EUR: Up (0.15%), €1.1578

    JPY: Up (0.20%), ¥214.076

    AUD: Up (0.13%), $1.894520

    Bitcoin (BTC/GBP): Down (-0.37%), £47,144.1

    Commodities

    Copper: Up (0.78%), 6.42364

    Gold: Up (0.01%), 4,330.29

    Brent Crude: Down (-1.30%), 92.202

    Natural Gas: Up (0.63%), 3.173

  • Bellway Maintains Profit Outlook Despite Slower Housing Market Conditions (BWY)

    Bellway Maintains Profit Outlook Despite Slower Housing Market Conditions (BWY)

    Bellway (LSE:BWY) has reaffirmed its full-year guidance after reporting resilient trading performance against a backdrop of softer conditions in the UK housing market. The housebuilder noted that customer demand moderated during the spring selling season as higher mortgage rates weighed on reservation activity, although overall sales volumes and cancellation rates have remained broadly stable. The company continues to expect full-year completions of between 9,300 and 9,500 homes and underlying operating profit of £320 million to £330 million, supported by a forward order book comprising 5,345 homes with a value of £1.57 billion.

    Management acknowledged that inflationary pressures have re-emerged in areas such as building materials and energy costs. However, Bellway believes these challenges are being mitigated through its scale, procurement efficiencies and the introduction of new standardised house designs. The company remains selective in its approach to land acquisition while continuing to expand its strategic land holdings, which now total approximately 47,000 plots. In addition, Bellway is progressing a £150 million share buyback programme and has increased its interim dividend, supported by a balance sheet with low levels of gearing.

    Since August 2025, the group has secured contracts on 6,744 plots, including a significant 1,900-plot development at Dunfermline that will strengthen its presence in Scotland. Bellway also expects to launch more than 40 new sales outlets during the second half of the year. With broader industry challenges continuing, management is focused on extracting value from its existing land portfolio, improving asset efficiency and maintaining strong cash generation to support enhanced shareholder returns over the medium term.

    The company’s outlook remains underpinned by solid fundamentals, including a strong balance sheet, continued growth opportunities and a constructive earnings outlook supported by cash generation and capital returns. These strengths are offset by weak technical indicators, with the shares trading well below key moving averages and displaying negative MACD momentum. Investors are also monitoring ongoing risks highlighted by management, including margin pressure and uncertainty surrounding building safety-related obligations.

    More about Bellway

    Bellway p.l.c. is one of the UK’s largest residential property developers, specialising in the construction of private and affordable housing across England, Scotland and Wales. The company operates through a nationwide network of around 240 sales outlets and serves a broad range of homebuyers.

    Its growth strategy is supported by a substantial owned and strategic land bank, providing a pipeline of future development opportunities. Bellway focuses on balancing volume growth, capital efficiency and cash generation while maintaining a disciplined approach to land investment and delivering long-term value for shareholders.

  • NextEnergy Solar Fund Schedules Investor Webcasts Ahead of Full-Year Results Release (NESF)

    NextEnergy Solar Fund Schedules Investor Webcasts Ahead of Full-Year Results Release (NESF)

    NextEnergy Solar Fund (LSE:NESF) has announced that it will publish its full-year results for the period ended 31 March 2026 on 22 June 2026. Following the release, the company will host a webcast presentation for investors and analysts later that day, featuring senior representatives from the fund and its investment adviser. The session will include a review of financial and operational performance, strategic developments and a live question-and-answer segment. A recording of the presentation and supporting materials will subsequently be made available on the company’s website.

    In addition to the institutional investor webcast, the fund’s investment adviser will hold a dedicated online presentation for retail shareholders on 23 June 2026 through the Investor Meet Company platform. Participants will have the opportunity to submit questions either before the event or during the live session. By organising separate presentations for institutional and retail audiences, the company is seeking to broaden engagement with shareholders and provide greater transparency ahead of the publication of its latest financial results and operational update.

    The fund’s outlook continues to be affected by weaker earnings performance, including a sharp decline in revenue and two consecutive years of reported losses. Technical indicators also remain challenging, with the shares trading below key moving averages and negative MACD momentum signalling a weak trend. These factors are partially offset by strong and improving operating cash flow, a debt-free balance sheet reported in 2025 and a notably high dividend yield. However, these strengths have yet to fully counterbalance the pressure from earnings weakness and subdued market sentiment.

    More about NextEnergy Solar Fund Limited

    NextEnergy Solar Fund Limited is a London-listed investment company focused on utility-scale solar power generation and energy storage infrastructure. The fund seeks to provide shareholders with attractive risk-adjusted returns, primarily through regular dividend distributions supported by long-term contracted cash flows.

    Its portfolio consists of diversified renewable energy assets, with a significant portion of revenues linked to inflation through UK government-backed subsidy mechanisms. As of 31 March 2026, the fund reported an unaudited gross asset value of £922 million and is classified as an Article 9 fund under the European Union’s sustainable finance framework, reflecting its commitment to sustainable and environmentally focused investments.

  • GSK Agrees $10.6bn Nuvalent Acquisition to Strengthen Lung Cancer Portfolio (GSK)

    GSK Agrees $10.6bn Nuvalent Acquisition to Strengthen Lung Cancer Portfolio (GSK)

    GSK (LSE:GSK) has reached an agreement to acquire Boston-based clinical-stage oncology company Nuvalent in a transaction valued at $10.6 billion. The acquisition will add three key lung cancer programmes to GSK’s pipeline, including the late-stage ROS1 inhibitor zidesamtinib, the ALK inhibitor neladalkib, and a HER2-targeted inhibitor, alongside a broader portfolio of precision oncology assets. The deal is intended to accelerate GSK’s expansion in the lung cancer market and establish a stronger commercial foundation for its B7-H3 antibody-drug conjugate, Ris-Rez.

    The company expects the acquisition to contribute positively to revenue growth from 2027 and to become accretive to core earnings per share from 2029. GSK plans to finance the transaction primarily through debt while maintaining its commitment to shareholder returns and preserving its investment-grade credit rating. The addition of Nuvalent’s targeted therapies is expected to enhance GSK’s oncology strategy and strengthen its position in the treatment of non-small cell lung cancer and other genetically defined cancer indications.

    GSK’s overall outlook continues to be supported by strong operational performance, including healthy margins, improving earnings and an attractive valuation profile. The shares also offer a dividend yield of approximately 3.47%, providing additional support for investors. These strengths are balanced by weaker technical indicators, with the stock trading below key moving averages and exhibiting negative MACD momentum. Financial considerations, including a meaningful level of leverage and periods of uneven free cash flow generation, also remain factors for investors to monitor.

    More about GlaxoSmithKline

    GSK is a global biopharmaceutical company focused on the development of vaccines, specialty medicines and innovative healthcare solutions. The group operates across a range of therapeutic areas and has increasingly prioritised oncology as a key driver of future growth.

    Through a combination of internal research, strategic partnerships and acquisitions, GSK continues to expand its pipeline in high-value disease areas, including respiratory medicine, infectious diseases and cancer. The company has been building a stronger presence in oncology, with particular emphasis on lung cancer and precision medicine approaches designed to target specific genetic drivers of disease.